Nitric oxide signaling in depression and antidepressant action

Neurobiology of Depression

Volumn , Issue , 2011, Pages 341-370

  Wegener, Gregers ^a   Mathé, Aleksander A ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880284024     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (298)

1. Akyol, O., Zoroglu, S. S., Armutcu, F., Sahin, S., and Gurel, A. 2004. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 18 (3):377-90
2. Alda, M. 2008. Nct00214877: Methylene blue for cognitive dysfunction in bipolar disorder. http://clinicaltrials.gov/show/NCT00214877. Accessed November 8th 2009
3. Arancio, O., Lev-Ram, V., Tsien, R. Y., Kandel, E. R., and Hawkins, R. D. 1996. Nitric oxide acts as a retrograde messenger during long-term potentiation in cultured hippocampal neurons. J Physiol (Paris) 90 (5-6):321-2
4. Arevalo, R., Sanchez, F., Alonso, J. R., Carretero, J., Vazquez, R., and Aijon, J. 1992. NADPH-diaphorase activity in the hypothalamic magnocellular neurosecretory nuclei of the rat. Brain Res Bull 28 (4):599-603
5. Aricioglu, F., and Altunbas, H. 2003. Is agmatine an endogenous anxiolytic/antidepressant agent? Ann N Y Acad Sci 1009:136-40
6. Arlt, S., Schulze, F., Eichenlaub, M., et al. 2008. Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease. Dement Geriatr Cogn Disord 26 (1):58-64
7. Assreuy, J., Cunha, F. Q., Liew, F. Y., and Moncada, S. 1993. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 108 (3):833-7
8. Babbedge, R. C., Bland-Ward, P. A., Hart, S. L., and Moore, P. K. 1993. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol 110 (1):225-8
9. Bagley, J., and Moghaddam, B. 1997. Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: Effects of pretreatment with saline or diazepam. Neuroscience 77 (1):65-73
10. Bannerman, D. M., Chapman, P. F., Kelly, P. A., Butcher, S. P., and Morris, R. G. 1994a. Inhibition of nitric oxide synthase does not impair spatial learning. J Neurosci 14 (12):7404-14
11. Bannerman, D. M., Chapman, P. F., Kelly, P. A., Butcher, S. P., and Morris, R. G. 1994b. Inhibition of nitric oxide synthase does not prevent the induction of long-term potentiation in vivo. J Neurosci 14 (12):7415-25
12. Barjavel, M. J., and Bhargava, H. N. 1995. Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: Kinetic analysis. Pharmacology 50 (3):168-74
13. Barragán-Rodríguez, L., Rodríguez-Morán, M., and Guerrero-Romero, F. 2008. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: A randomized, equivalent trial. Magnes Res 21 (4):218-23
14. Beckman, J. S. 1996. The physiological and pathological chemistry of nitric oxide. In Nitric Oxide: Principles and Actions, ed. J. Lancaster, 1-82. San Diego: Academic Press, Inc
15. Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., and Meador-Woodruff, J. H. 2007. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32 (9):1888-902
16. Bernstein, H. G., Stanarius, A., Baumann, B., et al. 1998. Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83 (3):867-75
17. Bernstein, H. G., Heinemann, A., Krell, D., et al. 2002. Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci 973:91-3
18. Bhat, G., Mahesh, V. B., Aguan, K., and Brann, D. W. 1996. Evidence that brain nitric oxide synthase is the major nitric oxide synthase isoform in the hypothalamus of the adult female rat and that nitric oxide potently regulates hypothalamic cGMP levels. Neuroendocrinology 64 (2):93-102
19. Bilbo, S. D., Hotchkiss, A. K., Chiavegatto, S., and Nelson, R. J. 2003. Blunted stress responses in delayed type hypersensitivity in mice lacking the neuronal isoform of nitric oxide synthase. J Neuroimmunol 140 (1-2):41-8
20. Bliss, T. V. P., and Collingridge, G. L. 1993. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361 (6407):31-9
21. Blottner, D., Grozdanovic, Z., and Gossrau, R. 1995. Histochemistry of nitric oxide synthase in the nervous system. Histochem J 27 (10):785-811
22. Bodoni, P. 1899. Le bleu de méthylène comme calmant chez le aliénés. Semaine Méd 7:56
23. Boger, R. H., Diemert, A., Schwedhelm, E., Luneburg, N., Maas, R., and Hecher, K. 2009a. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. Gynecol Obstet Invest 69 (1):1-13
24. Boger, R. H., Maas, R., Schulze, F., and Schwedhelm, E. 2009b. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 60:481-7
25. Boger, R. H., Sullivan, L. M., Schwedhelm, E., et al. 2009c. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119 (12):1592-600
26. Bohme, G. A., Bon, C., Lemaire, M., et al. 1993. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci U S A 90 (19):9191-4
27. Bonanno, G., Giambelli, R., Raiteri, L., et al. 2005. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of snare complex in hippocampus. J Neurosci 25 (13):3270-9
28. Bredt, D. S., and Snyder, S. H. 1989. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A 86 (22):9030-3
29. Bredt, D. S., and Snyder, S. H. 1994. Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem 63:175-95
30. Brenman, J. E., and Bredt, D. S. 1997. Synaptic signaling by nitric oxide. Curr Opin Neurobiol 7 (3):374-8
31. Brink, C. B., Clapton, J. D., Eagar, B. E., and Harvey, B. H. 2008. Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: Evidence from behavioural and neuro-receptor studies. J Neural Transm 115 (1):117-25
32. Buga, G. M., Griscavage, J. M., Rogers, N. E., and Ignarro, L. J. 1993. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 73 (5):808-12
33. Buttenschon, H. N., Mors, O., Ewald, H., et al. 2004. No association between a neuronal nitric oxide synthase (NOS1) gene polymorphism on chromosome 12q24 and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 124 (1):73-5
34. Caspi, A., Sugden, K., Moffitt, T. E., et al. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301 (5631):386-9
35. Ceccatelli, S., Grandison, L., Scott, R. E. M., Pfaff, D. W., and Kow, L. M. 1996. Estradiol regulation of nitric oxide synthase mRNAs in rat hypothalamus. Neuroendocrinology 64 (5):357-63
36. Chanrion, B., Mannoury La Cour, C., Bertaso, F., et al. 2007. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci U S A 104 (19):8119-24
37. Chapman, P. F., Atkins, C. M., Allen, M. T., Haley, J. E., and Steinmetz, J. E. 1992. Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport 3 (7):567-70
38. Chen, M., Cheng, C., Yan, M., et al. 2008. Involvement of capon and nitric oxide synthases in rat muscle regeneration after peripheral nerve injury. J Mol Neurosci 34 (1):89-100
39. Chiavegatto, S., Dawson, V. L., Mamounas, L. A., Koliatsos, V. E., Dawson, T. M., and Nelson, R. J. 2001. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci U S A 98 (3):1277-81
40. Chrapko, W. E., Jurasz, P., Radomski, M. W., Lara, N., Archer, S. L., and Le Melledo, J. M. 2004. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry 56 (2):129-34
41. Chrapko, W., Jurasz, P., Radomski, M. W., et al. 2006. Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients. Neuropsychopharmacology 31 (6):1286-93
42. Christopherson, K. S., Hillier, B. J., Lim, W. A., and Bredt, D. S. 1999. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 274 (39):27467-73
43. Cobb, B. L., Ryan, K. L., Frei, M. R., Guel-Gomez, V., and Mickley, G. A. 1995. Chronic administration of l-NAME in drinking water alters working memory in rats. Brain Res Bull 38 (2):203-7
44. Contestabile, A. 2000. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res Rev 32 (2-3):476-509
45. Corbett, J. A., and McDaniel, M. L. 1996. The use of aminoguanidine, a selective iNOS inhibitor, to evaluate the role of nitric oxide in the development of autoimmune diabetes. Methods 10 (1):21-30
46. Costa, A., Trainer, P., Besser, M., and Grossman, A. 1993. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res 605 (2):187-92
47. Cui, H., Hayashi, A., Sun, H. S., et al. 2007. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J Neurosci 27 (37):9901-15
48. da Silva, G. D., Matteussi, A. S., dos Santos, A. R., Calixto, J. B., and Rodrigues, A. L. 2000. Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. Neuroreport 11 (17):3699-702
49. Das, I., Khan, N. S., Puri, B. K., and Hirsch, S. R. 1996. Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neurosci Lett 215 (3):209-11
50. Dawson, T. M., and Dawson, V. L. 1995. ADP-ribosylation as a mechanism for the action of nitric oxide in the nervous system. New Horiz 3 (1):85-92
51. Dawson, T. M., and Snyder, S. H. 1994. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. J Neurosci 14 (9):5147-59
52. Dawson, T. M., Sasaki, M., Gonzalez-Zulueta, M., and Dawson, V. L. 1998. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways. Prog Brain Res 118:3-11
53. De Oliveira, R. M. W., Deakin, J. F., and Guimaraes, F. S. 2000. Neuronal nitric oxide synthase (NOS) expression in the hippocampal formation of patients with schizophrenia and affective disorder. J Psychopharmacol 14 (Suppl):1-8
54. de Vente, J., Hopkins, D. A., Markerink-Van, I. M., Emson, P. C., Schmidt, H. H., and Steinbusch, H. W. 1998. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain. Neuroscience 87 (1):207-41
55. Denninger, J. W., and Marletta, M. A. 1999. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1411 (2-3):334-50
56. Dhir, A., and Kulkarni, S. K. 2007. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol 568 (1-3):177-85
57. Duman, R. S., Malberg, J., and Nakagawa, S. 2001a. Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther 299 (2):401-7
58. Duman, R. S., Nakagawa, S., and Malberg, J. 2001b. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25 (6):836-44
59. Ehninger, D., and Kempermann, G. 2008. Neurogenesis in the adult hippocampus. Cell Tissue Res 331 (1):243-50
60. Ehringer, H., Hornykiewicz, O., and Lechner, K. 1961. Die Wirkung von Methylenblau auf die Monoaminoxydase und den Katecholamin-und 5-Hydroxytryptaminstoffwechsel des Gehirnes. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 241:568-82
61. Ergun, Y., and Ergun, U. G. 2007. Prevention of pro-depressant effect of l-arginine in the forced swim test by NG-nitro-l-arginine and [1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one]. Eur J Pharmacol 554 (2-3):150-4
62. Eroglu, L., and Caglayan, B. 1997. Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacol Res 36 (5):381-5
63. Estall, L. B., Grant, S. J., and Cicala, G. A. 1993. Inhibition of nitric oxide (NO) production selectively impairs learning and memory in the rat. Pharmacol Biochem Behav 46 (4):959-62
64. Feyissa, A. M., Chandran, A., Stockmeier, C. A., and Karolewicz, B. 2009. Reduced levels of NR2A and NR2B subunits of NMDA receptor and PAD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry 33:70-5
65. Finkel, M. S., Laghrissi-Thode, F., Pollock, B. G., and Rong, J. 1996. Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacol Bull 32 (4):653-8
66. Forstermann, U., Schmidt, H. H., Pollock, J. S., et al. 1991. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42 (10):1849-57
67. Forstermann, U., Gath, I., Schwarz, P., Closs, E. I., and Kleinert, H. 1995. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol 50 (9):1321-32
68. Fossier, P., Blanchard, B., Ducrocq, C., Leprince, C., Tauc, L., and Baux, G. 1999. Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation. Neuroscience 93 (2):597-603
69. Frey, C., Narayanan, K., McMillan, K., Spack, L., Gross, S. S., Masters, B. S., and Griffith, O. W. 1994. l-Thiocitrulline. A stereospecific, heme-binding inhibitor of nitric-oxide synthases. J Biol Chem 269 (42):26083-91
70. Gadek-Michalska, A., and Bugajski, J. 2008. Nitric oxide in the adrenergic-and CRH-induced activation of hypothalamic-pituitary-adrenal axis. J Physiol Pharmacol 59 (2):365-78
71. Galecki, P., Maes, M., Florkowski, A., et al. 2011. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord 129(1-3):175-82
72. Galimberti, D., Scarpini, E., Venturelli, E., et al. 2008. Association of a NOS1 promoter repeat with Alzheimer's disease. Neurobiol Aging 29 (9):1359-65
73. Gardiner, S. M., Kemp, P. A., March, J. E., and Bennett, T. 1996. Influence of aminoguanidine and the endothelin antagonist, sb 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats. Br J Pharmacol 118 (7):1822-8
74. Garthwaite, J., and Boulton, C. L. 1995. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57:683-706
75. Garthwaite, J., Charles, S. L., and Chess-Williams, R. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336 (6197):385-8
76. Garthwaite, J., Garthwaite, G., Palmer, R. M., and Moncada, S. 1989. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 172 (4-5):413-16
77. Gaston, B. M., Carver, J., Doctor, A., and Palmer, L. A. 2003. S-nitrosylation signaling in cell biology. Mol Interv 3 (5):253-63
78. Ghasemi, M., Sadeghipour, H., Mosleh, A., Sadeghipour, H. R., Mani, A. R., and Dehpour, A. R. 2008. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol 18 (5):323-32
79. Gilhotra, N., and Dhingra, D. 2009. Involvement of NO-cGMP pathway in anti-anxiety effect of aminoguanidine in stressed mice. Prog Neuropsychopharmacol Biol Psychiatry 33(8):1502-7
80. Gillman, P. K. 2008. Methylene blue is a potent monoamine oxidase inhibitor. Can J Anaesth 55 (5):311-12
81. Givalois, L., Li, S., and Pelletier, G. 2002. Central nitric oxide regulation of the hypothalamic-pituitary-adrenocortical axis in adult male rats. Mol Brain Res 102 (1-2):1-8
82. Griffiths, M. J., Messent, M., MacAllister, R. J., and Evans, T. W. 1993. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 110 (3):963-8
83. Griffiths, M. J., Messent, M., Curzen, N. P., and Evans, T. W. 1995. Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase. Am J Respir Crit Care Med 152 (5 Pt 1):1599-604
84. Griffith, O. W., and Kilbourn, R. G. 1996. Nitric oxide synthase inhibitors: Amino acids. Methods Enzymol 268:375-92
85. Halaris, A., and Piletz, J. E. 2001. Imidazoline receptors: Possible involvement in the pathophysiology and treatment of depression. Hum Psychopharmacol Clin Exp 16 (1):65-9
86. Halaris, A., and Piletz, J. E. 2003. Relevance of imidazoline receptors and agmatine to psychiatry: A decade of progress. Ann N Y Acad Sci 1009:1-20
87. Halaris, A., Zhu, H., Feng, Y., and Piletz, J. E. 1999. Plasma agmatine and platelet imidazoline receptors in depression. Ann N Y Acad Sci 881:445-51
88. Handy, R. L., Harb, H. L., Wallace, P., Gaffen, Z., Whitehead, K. J., and Moore, P. K. 1996. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects. Br J Pharmacol 119 (2):423-31
89. Handy, R. L., and Moore, P. K. 1997. Mechanism of the inhibition of neuronal nitric oxide synthase by 1-(2-tri fluoromethylphenyl) imidazole (TRIM). Life Sci 60 (25):L389-94
90. Handy, R. L., Wallace, P., Gaffen, Z. A., Whitehead, K. J., and Moore, P. K. 1995. The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br J Pharmacol 116 (5):2349-50
91. Hara, H., Waeber, C., Huang, P. L., Fujii, M., Fishman, M. C., and Moskowitz, M. A. 1996. Brain distribution of nitric oxide synthase in neuronal or endothelial nitric oxide synthase mutant mice using [3H]l-NG-nitro-arginine autoradiography. Neuroscience 75 (3):881-90
92. Harkin, A. J., Bruce, K. H., Craft, B., and Paul, I. A. 1999. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 372 (3):207-13
93. Harkin, A., Connor, T. J., Walsh, M., St John, N., and Kelly, J. P. 2003. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 44 (5):616-23
94. Harkin, A., Connor, T. J., Burns, M. P., and Kelly, J. P. 2004. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol 14 (4):274-81
95. Harvey, B. H., Oosthuizen, F., Brand, L., Wegener, G., and Stein, D. J. 2004. Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology 175 (4):494-502
96. Harvey, B. H., Bothma, T., Nel, A., Wegener, G., and Stein, D. J. 2005. Involvement of the NMDA receptor, NO-cyclic GMP and nuclear factor k-beta in an animal model of repeated trauma. Hum Psychopharmacol Clin Exp 20 (5):367-73
97. Hasan, K., Heesen, B. J., Corbett, J. A., et al. 1993. Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 249 (1):101-6
98. Heiberg, I. L., Wegener, G., and Rosenberg, R. 2002. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav Brain Res 134 (1-2):479-84
99. Herken, H., Gurel, A., Selek, S., et al. 2007. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment. Arch Med Res 38 (2):247-52
100. Herrera-Guzman, I., Gudayol-Ferre, E., Herrera-Guzman, D., Guardia-Olmos, J., Hinojosa-Calvo, E., and Herrera-Abarca, J. E. 2009. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. J Psychiatr Res 43 (9):855-63
101. Herzberg, L., and Herzberg, B. 1977. Mood change and magnesium. A possible interaction between magnesium and lithium? J Nerv Ment Dis 165 (6):423-6
102. Hess, D. T., Patterson, S. I., Smith, D. S., and Skene, J. H. 1993. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 366 (6455):562-5
103. Hibbs, J. B. Jr., Taintor, R. R., and Vavrin, Z. 1987. Macrophage cytotoxicity: Role for l-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235 (4787):473-6
104. Hindley, S., Juurlink, B. H., Gysbers, J. W., Middlemiss, P. J., Herman, M. A., and Rathbone, M. P. 1997. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J Neurosci Res 47 (4):427-39
105. Hojgaard Rasmussen, H., Bo Mortensen, P., and Jensen, I. W. 1989. Depression and magnesium deficiency. Int J Psychiatry Med 19 (1):57-63
106. Holderbach, R., Clark, K., Moreau, J. L., Bischofberger, J., and Normann, C. 2007. Enhanced long-term synaptic depression in an animal model of depression. Biol Psychiatry 62 (1):92-100
107. Holscher, C. 1994. 7-Nitro indazole, a neuron-specific nitric oxide synthase inhibitor, produces amnesia in the chick. Learn Mem 1 (4):213-16
108. Holscher, C., McGlinchey, L., Anwyl, R., and Rowan, M. J. 1996. 7-Nitro indazole, a selective neuronal nitric oxide synthase inhibitor in vivo, impairs spatial learning in the rat. Learn Mem 2 (6):267-78
109. Holstad, M., Jansson, L., and Sandler, S. 1996. Effects of aminoguanidine on rat pancreatic islets in culture and on the pancreatic islet blood flow of anaesthetized rats. Biochem Pharmacol 51 (12):1711-17
110. Hua, Y., Huang, X. Y., Zhou, L., et al. 2008. DETA/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis. Psychopharmacology 200 (2):231-42
111. Inan, S. Y., Yalcin, I., and Aksu, F. 2004. Dual effects of nitric oxide in the mouse forced swimming test: Possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol Biochem Behav 77 (3):457-64
112. Ishibashi, Y., Shimada, T., Murakami, Y., et al. 2001. An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure. J Am Coll Cardiol 38 (5):1470-6
113. Jakubovic, A., and Necina, J. 1963. The effect of methylene blue on the monoamine oxidase activity of the liver and brain of rats after various routes of administration. Arzneimittelforschung 13:134-6
114. Jankord, R., McAllister, R. M., Ganjam, V. K., and Laughlin, M. H. 2009. Chronic inhibition of nitric oxide synthase augments the ACTH response to exercise. Am J Physiol Regul Integr Comp Physiol 296 (3):R728-34
115. Jefferys, D., and Funder, J. 1996. Nitric oxide modulates retention of immobility in the forced swimming test in rats. Eur J Pharmacol 295 (2-3):131-5
116. Jesse, C. R., Bortolatto, C. F., Savegnago, L., Rocha, J. B., and Nogueira, C. W. 2008. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 32 (8):1838-43
117. Joca, S. R., and Guimaraes, F. S. 2006. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology (Berl) 185 (3):298-305
118. Johnson, M. D., and Ma, P. M. 1993. Localization of NADPH diaphorase activity in monoaminergic neurons of the rat brain. J Comp Neurol 332 (4):391-406
119. Juch, M., Smalla, K. H., Kahne, T., et al. 2009. Congenital lack of nNOS impairs long-term social recognition memory and alters the olfactory bulb proteome. Neurobiol Learn Mem 92 (4):469-84
120. Kaehler, S. T., Singewald, N., Sinner, C., and Philippu, A. 1999. Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res 835 (2):346-9
121. Karolewicz, B., Paul, I. A., and Antkiewicz-Michaluk, L. 2001. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Pol J Pharmacol 53 (6):587-96
122. Karolewicz, B., Szebeni, K., Stockmeier, C. A., et al. 2004. Low nNOS protein in the locus coeruleus in major depression. J Neurochem 91 (5):1057-66
123. Kendler, K. S., Thornton, L. M., and Gardner, C. O. 2000. Stressful life events and previous episodes in the etiology of major depression in women: An evaluation of the 'kindling' hypothesis. Am J Psychiatry 157 (8):1243-51
124. Kerwin, J. F. Jr., and Heller, M. 1994. The arginine-nitric oxide pathway: A target for new drugs. Med Res Rev 14 (1):23-74
125. Kim, W. K., Choi, Y. B., Rayudu, P. V., Das, P., Asaad, W., Arnelle, D. R., Stamler, J. S., and Lipton, S. A. 1999. Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-. Neuron 24 (2):461-9
126. Kim, Y. K., Paik, J. W., Lee, S. W., Yoon, D., Han, C., and Lee, B. H. 2006. Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog Neuropsychopharmacol Biol Psychiatry 30 (6):1091-6
127. Kiss, J. P., and Vizi, E. S. 2001. Nitric oxide: A novel link between synaptic and nonsynaptic transmission. Trends Neurosci 24 (4):211-15
128. Knott, A. B., and Bossy-Wetzel, E. 2009. Nitric oxide in health and disease of the nervous system. Antioxid Redox Signal 11 (3):541-54
129. Knowles, R. G., and Moncada, S. 1994. Nitric oxide synthases in mammals. Biochem J 298 (Pt 2):249-58
130. Kowall, N. W., Ferrante, R. J., Beal, M. F., et al. 1987. Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: A combined immunocytochemical and enzyme histochemical study. Neuroscience 20 (3):817-28
131. Krass, M., Wegener, G., Vasar, E., and Volke, V. 2008. Antidepressant-like effect of agmatine is not mediated by serotonin. Behav Brain Res 188 (2):324-8
132. Krass, M., Wegener, G., Vasar, E., and Volke, V. 2011. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis. Behav Brain Res 218 (1):57-63
133. Kuhn, D. M., and Arthur, R. E. Jr. 1996. Inactivation of brain tryptophan hydroxylase by nitric oxide. J Neurochem 67 (3):1072-7
134. Kuhn, D. M., and Arthur, R. Jr. 1997. Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: Attack on critical sulfhydryls that spare the enzyme iron center. J Neurosci 17 (19):7245-51
135. Kurt, M., Bilge, S. S., Aksoz, E., Kukula, O., Celik, S., and Kesim, Y. 2004. Effect of sildenafil on anxiety in the plus-maze test in mice. Pol J Pharmacol 56 (3):353-7
136. Laitinen, J. T., Laitinen, K. S., Tuomisto, L., and Airaksinen, M. M. 1994. Differential regulation of cyclic GMP levels in the frontal cortex and the cerebellum of anesthetized rats by nitric oxide: An in vivo microdialysis study. Brain Res 668 (1-2):117-21
137. Lassen, L. H., Ashina, M., Christiansen, I., Ulrich, V., and Olesen, J. 1997. Nitric oxide synthase inhibition in migraine [letter]. Lancet 349 (9049):401-2
138. Lassen, L. H., Ashina, M., Christiansen, I., et al. 1998. Nitric oxide synthase inhibition: A new principle in the treatment of migraine attacks. Cephalgia 18 (1):27-32
139. Lee, B. H., Lee, S. W., Yoon, D., et al. 2006. Increased plasma nitric oxide metabolites in suicide attempters. Neuropsychobiology 53 (3):127-32
140. Lemaire, J. F., and McPherson, P. S. 2006. Binding of vac14 to neuronal nitric oxide synthase: Characterisation of a new internal PDZ-recognition motif. FEBS Lett 580 (30):6948-54
141. Li, G., Regunathan, S., Barrow, C. J., Eshraghi, J., Cooper, R., and Reis, D. J. 1994. Agmatine: An endogenous clonidine-displacing substance in the brain. Science 263 (5149):966-9
142. Li, N., Lee, B., Liu, R. J., et al. 2010. MTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329 (5994):959-64
143. Li, Y. F., Gong, Z. H., Cao, J. B., Wang, H. L., Luo, Z. P., and Li, J. 2003. Antidepressant-like effect of agmatine and its possible mechanism. Eur J Pharmacol 469 (1-3):81-8
144. Linden, D. J., Dawson, T. M., and Dawson, V. L. 1995. An evaluation of the nitric oxide/cGMP/cGMP-dependent protein kinase cascade in the induction of cerebellar long-term depression in culture. J Neurosci 15 (7 Pt 2):5098-105
145. Lonart, G., and Johnson, K. M. 1994. Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes. J Neurochem 63 (6):2108-17
146. Lonart, G., Cassels, K. L., and Johnson, K. M. 1993. Nitric oxide induces calcium-dependent [3H]dopamine release from striatal slices. J Neurosci Res 35 (2):192-8
147. Lorrain, D. S., and Hull, E. M. 1993. Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport 5 (1):87-9
148. Lowenstein, C. J., and Snyder, S. H. 1992. Nitric oxide, a novel biologic messenger. Cell 70 (5):705-7
149. Lowy, M. T., Wittenberg, L., and Yamamoto, B. K. 1995. Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J Neurochem 65 (1):268-74
150. Luo, D., and Vincent, S. R. 1994. NMDA-dependent nitric oxide release in the hippocampus in vivo: Interactions with noradrenaline. Neuropharmacology 33 (11):1345-50
151. Machado-Vieira, R., Salvadore, G., Diazgranados, N., and Zarate, C. A. Jr. 2009. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 123 (2):143-50
152. Madison, D. V., Malenka, R. C., and Nicoll, R. A. 1991. Mechanisms underlying long-term potentiation of synaptic transmission. Annu Rev Neurosci 14:379-97
153. Madrigal, J. L., Moro, M. A., Lizasoain, I., et al. 2001. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem 76 (2):532-8
154. Madrigal, J. L. M., Moro, M. A., Lizasoain, I., Lorenzo, P., and Leza, J. C. 2002. Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide. Brain Res 938 (1-2):87-91
155. Maeng, S., and Zarate, C. A. Jr. 2007. The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9 (6):467-74
156. Malenka, R. C. 1994. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78 (4):535-8
157. Marletta, M. A. 1993. Nitric oxide synthase structure and mechanism. J Biol Chem 268 (17):12231-4
158. Matarredona, E. R., Murillo-Carretero, M., Moreno-López, B., and Estrada, C. 2004. Nitric oxide synthesis inhibition increases proliferation of neural precursors isolated from the postnatal mouse subventricular zone. Brain Res 995 (2):274-84
159. Mayer, B., Brunner, F., and Schmidt, K. 1993a. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45 (2):367-74
160. Mayer, B., Brunner, F., and Schmidt, K. 1993b. Novel actions of methylene blue. Eur Heart J 14 (Suppl I): 22-6
161. Mayer, B., Klatt, P., Werner, E. R., and Schmidt, K. 1994. Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole. Neuropharmacology 33 (11):1253-9
162. Meffert, M. K., Premack, B. A., and Schulman, H. 1994. Nitric oxide stimulates Ca(2+)-independent synaptic vesicle release. Neuron 12 (6):1235-44
163. Meffert, M. K., Calakos, N. C., Scheller, R. H., and Schulman, H. 1996. Nitric oxide modulates synaptic vesicle docking fusion reactions. Neuron 16 (6):1229-36
164. Michael-Titus, A. T., Bains, S., Jeetle, J., and Whelpton, R. 2000. Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex-A possible mechanism of neuroprotection in major depression? Neuroscience 100 (4):681-4
165. Miki, N., Kawabe, Y., and Kuriyama, K. 1977. Activation of cerebral guanylate cyclase by nitric oxide. Biochem Biophys Res Commun 75 (4):851-6
166. Mizuno, M., Yamada, K., Olariu, A., Nawa, H., and Nabeshima, T. 2000. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci 20 (18):7116-21
167. Mogensen, J., Wortwein, G., Gustafson, B., and Ermens, P. 1995a. l-Nitroarginine reduces hippocampal mediation of place learning in the rat. Neurobiol Learn Mem 64 (1):17-24
168. Mogensen, J., Wortwein, G., Hasman, A., Nielsen, P., and Wang, Q. 1995b. Functional and neurochemical profile of place learning after l-nitro-arginine in the rat. Neurobiol Learn Mem 63 (1):54-65
169. Moncada, S., Palmer, R. M., and Higgs, E. A. 1989. Biosynthesis of nitric oxide from l-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38 (11):1709-15
170. Moore, P. K., Babbedge, R. C., Wallace, P., Gaffen, Z. A., and Hart, S. L. 1993. 7-nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 108 (2):296-7
171. Mori, K., Togashi, H., Ueno, K. I., Matsumoto, M., and Yoshioka, M. 2001. Aminoguanidine prevented the impairment of learning behavior and hippocampal long-term potentiation following transient cerebral ischemia. Behav Brain Res 120 (2):159-68
172. Mungrue, I. N., and Bredt, D. S. 2004. nNOS at a glance: Implications for brain and brawn. J Cell Sci 117 (Pt 13):2627-9
173. Murad, F., Mittal, C. K., Arnold, W. P., Katsuki, S., and Kimura, H. 1978. Guanylate cyclase: Activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res 9:145-58
174. Murck, H. 2002. Magnesium and affective disorders. Nutr Neurosci 5 (6):375-89
175. Musazzi, L., Milanese, M., Farisello, P., et al. 2010. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: The dampening action of antidepressants. PLoS One 5 (1): e8566
176. Narsapur, S. L., and Naylor, G. J. 1983. Methylene blue. A possible treatment for manic depressive psychosis. J Affect Disord 5 (2):155-61
177. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J 6 (12):3051-64
178. Nathan, C., and Xie Q. W. 1994. Regulation of biosynthesis of nitric oxide. J Biol Chem 269 (19):13725-8
179. Naudon, L., Hotte, M., and Jay, T. M. 2007. Effects of acute and chronic antidepressant treatments on memory performance: A comparison between paroxetine and imipramine. Psychopharmacology (Berl) 191 (2):353-64
180. Naylor, G. G., and Smith, A. H. 1982. Reduction of vanadate, a possible explanation of the effect of phenothiazines in manic-depressive psychosis. Lancet 1 (8268):395-6
181. Naylor, G. J. 1984. Vanadium and manic depressive psychosis. Nutr Health 3 (1-2):79-85
182. Naylor, G. J., Dick, D. A., Johnston, B. B., et al. 1981. Possible explanation for therapeutic action of lithium, and a possible substitute (methylene-blue) [letter]. Lancet 2 (8256):1175-6
183. Naylor, G. J., Martin, B., Hopwood, S. E., and Watson, Y. 1986. A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biol Psychiatry 21 (10):915-20
184. Naylor, G. J., Smith, A. H., and Connelly, P. 1987. A controlled trial of methylene blue in severe depressive illness. Biol Psychiatry 22 (5):657-9
185. Naylor, G. J., Smith, A. H., and Connelly P. 1988. Methylene blue in mania [letter]. Biol Psychiatry 24 (8):941-2
186. Nelson, R. J. 2005. Effects of nitric oxide on the HPA axis and aggression. In Molecular Mechanisms Influencing Aggressive Behaviours. Novartis Foundation Symposium 268: 147-70
187. Nelson, R. J., Demas, G. E., Huang, P. L., et al. 1995. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378 (6555):383-6
188. Nelson, R. J., Trainor, B. C., Chiavegatto, S., and Demas, G. E. 2006. Pleiotropic contributions of nitric oxide to aggressive behavior. Neurosci Biobehav Rev 30 (3):346-55
189. Normann, C., Schmitz, D., Furmaier, A., Doing, C., and Bach, M. 2007. Long-term plasticity of visually evoked potentials in humans is altered in major depression. Biol Psychiatry 62 (5):373-80
190. Nudmamud-Thanoi, S., and Reynolds, G. P. 2004. The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci Lett 372 (1-2):173-7
191. Nylén, A., Skagerberg, G., Alm, P., Larsson, B., Holmqvist, B., and Andersson, K. E. 2001. Nitric oxide synthase in the hypothalamic paraventricular nucleus of the female rat; organization of spinal projections and coexistence with oxytocin or vasopressin. Brain Res 908 (1):10-24
192. O'Dell, T. J., Hawkins, R. D., Kandel, E. R., and Arancio, O. 1991. Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci U S A 88 (24):11285-9
193. O'Dell, T. J., Huang, P. L., Dawson, T. M., et al. 1994. Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 265 (5171):542-6
194. Ogawa, T., Kimoto, M., Watanabe, H., and Sasaoka, K. 1987. Metabolism of NG,NG-and NG,N'G-dimethylarginine in rats. Arch Biochem Biophys 252 (2):526-37
195. Ohno, M., Yamamoto, T., and Watanabe, S. 1993. Deficits in working memory following inhibition of hippocampal nitric oxide synthesis in the rat. Brain Res 632 (1-2):36-40
196. Ohno, M., Yamamoto, T., and Watanabe, S. 1994. Intrahippocampal administration of the NO synthase inhibitor l-NAME prevents working memory deficits in rats exposed to transient cerebral ischemia. Brain Res 634 (1):173-7
197. Okada, D., Yap, C. C., Kojima, H., Kikuchi, K., and Nagano, T. 2004. Distinct glutamate receptors govern differential levels of nitric oxide production in a layer-specific manner in the rat cerebellar cortex. Neuroscience 125 (2):461-72
198. Okumura, T., Kishi, T., Okochi, T., et al. 2010. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population. Neuropsychobiology 61 (2):57-63
199. Olesen, J., and Leonardi, M. 2003. The burden of brain diseases in Europe. Eur J Neurol 10 (5):471-7
200. Olesen, J., Sobscki, P., Truelsen, T., Sestoft, D., and Jonsson, B. 2008. Cost of disorders of the brain in Denmark. Nord J Psychiatry 62 (2):114-20
201. Oliveira, R. M., Guimaraes, F. S., and Deakin, J. F. 2008. Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res 41 (4):333-41
202. Olivenza, R., Moro, M. A., Lizasoain, I., et al. 2000. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem 74 (2):785-91
203. Olmos, G., De Gregorio-Rocasolano, N., Paz Regalado, M., et al. 1999. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 127 (6):1317-26
204. Oosthuizen, F., Wegener, G., and Harvey, B. H. 2005. Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): Evidence from an animal model. Neuropsychiat Dis Treat 1 (2):109-23
205. Orlando, G. F., Langnaese, K., Schulz, C., Wolf, G., and Engelmann, M. 2008. Neuronal nitric oxide synthase gene inactivation reduces the expression of vasopressin in the hypothalamic paraventricular nucleus and of catecholamine biosynthetic enzymes in the adrenal gland of the mouse. Stress 11 (1):42-51
206. Pacher, P., Beckman, J. S., and Liaudet, L. 2007. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 (1):315-424
207. Packer, M. A., Stasiv, Y., Benraiss, A., et al. 2003. Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci U S A 100 (16):9566-71
208. Palmer, R. M., Ferrige, A. G., and Moncada, S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (6122):524-6
209. Papa, M., Pellicano, M. P., and Sadile, A. G. 1994. Nitric oxide and long-term habituation to novelty in the rat. Ann N Y Acad Sci 738:316-24
210. Pavlinac, D., Langer, R., Lenhard, L., and Deftos, L. 1979. Magnesium in affective disorders. Biol Psychiatry 14 (4):657-61
211. Plech, A., Klimkiewicz, T., and Maksym, B. 2003. Effect of l-arginine on memory in rats. Pol J Pharmacol 55 (6):987-92
212. Pogun, S., and Kuhar, M. J. 1994. Regulation of neurotransmitter reuptake by nitric oxide. Ann N Y Acad Sci 738:305-15:305-15
213. Pogun, S., Baumann, M. H., and Kuhar, M. J. 1994a. Nitric oxide inhibits [3H]dopamine uptake. Brain Res 641 (1):83-91
214. Pogun, S., Dawson, V., and Kuhar, M. J. 1994b. Nitric oxide inhibits 3H-glutamate transport in synaptosomes. Synapse 18 (1):21-6
215. Poleszak, E., Wlaz, P., Kedzierska, E., et al. 2007. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav 88 (2):158-64
216. Prast, H., and Philippu. A. 2001. Nitric oxide as modulator of neuronal function. Prog Neurobiol 64 (1):51-68
217. Radi, R., and Rubbo, H. 2001. Antioxidant properties of nitric oxide. In Handbook of Antioxidants, 2nd edn., ed. E. Cadenas and L. Parker, 689-706. New York: Marcel Dekker Inc
218. Radi, R., Beckman, J. S., Bush, K. M.,. and Freeman, B. A. 1991. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288 (2):481-7
219. Regunathan, S., and Reis, D. J. 1996. Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 36:511-44
220. Reif, A., Herterich, S., Strobel, A., et al. 2006a. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11 (3):286-300
221. Reif, A., Strobel, A., Jacob, C. P., et al. 2006b. A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder. Int J Neuropsychopharmacol 9 (1):13-20
222. Reif, A., Jacob, C. P., Rujescu, D., et al. 2009. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 66 (1):41-50
223. Rengasamy, A., and Johns, R. A. 1993. Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 44 (1):124-8
224. Reznikov, L. R., Grillo, C. A., Piroli, G. G., Pasumarthi, R. K., Reagan, L. P., and Fadel, J. 2007. Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: Differential effects of antidepressant treatment. Eur J Neurosci 25 (10):3109-14
225. Riefler, G. M., and Firestein, B. L. 2001. Binding of neuronal nitric-oxide synthase (nNOS) to carboxyl-terminal-binding protein (CTBP) changes the localization of CTBP from the nucleus to the cytosol: A novel function for targeting by the PDZ domain of nNOS. J Biol Chem 276 (51):48262-8
226. Rivier, C., and Shen, G. H. 1994. In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1β, vasopressin, and oxytocin. J Neurosci 14 (4):1985-93
227. Romero-Grimaldi, C., Moreno-López, B., and Estrada, C. 2008. Age-dependent effect of nitric oxide on subventricular zone and olfactory bulb neural precursor proliferation. J Comp Neurol 506 (2):339-46
228. Rubbo, H., Radi, R., Trujillo, M., et al. 1994. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269 (42):26066-75
229. Rydgren, T., and Sandler, S. 2002. Efficacy of 1400 w, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo. Eur J Endocrinol 147 (4):543-51
230. Saitoh, F., Tian, Q. B., Okano, A., Sakagami, H., Kondo, H., and Suzuki, T. 2004. NIDD, a novel DHHC-containing protein, targets neuronal nitric-oxide synthase (nNOS) to the synaptic membrane through a PDZ-dependent interaction and regulates nNOS activity. J Biol Chem 279 (28):29461-8
231. Salaris, S. C., Babbs, C. F., and Voorhees, W. D. III. 1991. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem Pharmacol 42 (3):499-506
232. Salter, M., Duffy, C., Garthwaite, J., and Strijbos, P. J. 1995. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of N omega-nitro-l-arginine (l-NA) and its methyl ester (l-NAME). Neuropharmacology 34 (6):639-49
233. Sanchez, F., Moreno, M. N., Vacas, P., Carretero, J., and Vazquez, R. 1999. Swim stress enhances the NADPH-diaphorase histochemical staining in the paraventricular nucleus of the hypothalamus. Brain Res 828 (1-2):159-62
234. Santarelli, L., Saxe, M., Gross, C., et al. 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (5634):805-9
235. Sattler, R., Xiong, Z., Lu, W. Y., Hafner, M., MacDonald, J. F., and Tymianski, M. 1999. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284 (5421): 1845-8
236. Schmidt, H. H., Pollock, J. S., Nakane, M., Forstermann, U., and Murad, F. 1992. Ca2+/calmodulin-regulated nitric oxide synthases. Cell Calcium 13 (6-7):427-34
237. Schmidt, H. H., Lohmann, S. M., and Walter, U. 1993. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1178 (2):153-75
238. Schuman, E. M., and Madison, D. V. 1991. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254 (5037):1503-6
239. Segovia, G., Porras, A., and Mora, F. 1994. Effects of a nitric oxide donor on glutamate and GABA release in striatum and hippocampus of the conscious rat. Neuroreport 5 (15):1937-40
240. Segovia, G., Del Arco, A., and Mora, F. 1997. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: A microdialysis study. J Neurochem 69 (4):1476-83
241. Segovia, G., Del Arco, A., and Mora, F. 1999. Role of glutamate receptors and glutamate transporters in the regulation of the glutamate-glutamine cycle in the awake rat. Neurochem Res 24 (6):779-83
242. Selley, M. L. 2004. Increased (e)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. J Affect Disord 80 (2-3):249-56
243. Shariful Islam, A. T. M., Kuraoka, A., and Kawabuchi, M. 2003. Morphological basis of nitric oxide production and its correlation with the polysialylated precursor cells in the dentate gyrus of the adult guinea pig hippocampus. Anat Sci Int 78 (2):98-103
244. Shimabukuro, M., Ohneda, M., Lee, Y., and Unger, R. H. 1997. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 100 (2):290-5
245. Siepmann, M., Grossmann, J., Muck-Weymann, M., and Kirch W. 2003. Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology (Berl) 168 (3):293-8
246. Simonian, S. X., and Herbison, A. E. 1996. Localization of neuronal nitric oxide synthase-immunoreactivity within sub-populations of noradrenergic a1 and a2 neurons in the rat. Brain Res 732 (1-2):247-52
247. Singewald, N., Sinner, C., Hetzenauer, A., Sartori, S. B., and Murck, H. 2004. Magnesium-deficient diet alters depression-and anxiety-related behavior in mice-Influence of desipramine and Hypericum perforatum extract. Neuropharmacology 47 (8):1189-97
248. Spiacci, A. Jr., Kanamaru, F., Guimaraes, F. S., and Oliveira, R. M. 2008. Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacol Biochem Behav 88 (3):247-55
249. Spolidorio, P. C., Echeverry, M. B., Iyomasa, M., Guimaraes, F. S., and Del Bel, E. A. 2007. Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus. Psychopharmacology (Berl) 195 (2):183-92
250. Srivastava, N., Barthwal, M. K., Dalal, P. K., et al. 2002. A study on nitric oxide, beta-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression. J Affect Disord 72 (1):45-52
251. Stamler. J. S. 1994. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78 (6):931-6
252. Stamler, J. S. 1995. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr Top Microbiol Immunol 196:19-36
253. Stamler, J. S., Lamas, S., and Fang, F. C. 2001. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 106 (6):675-83
254. Stanford, S. C., Stanford, B. J., and Gillman, P. K. 2010. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: An update on a case report of post-operative delirium. J Psychopharmacol 24 (10):1433-8
255. Strasser, A., McCarron, R. M., Ishii, H., Stanimirovic, D., and Spatz, M. 1994. l-Arginine induces dopamine release from the striatum in vivo. Neuroreport 5 (17):2298-300
256. Suarez-Pinzon, W. L., Mabley, J. G., Strynadka, K., Power, R. F., Szabo, C., and Rabinovitch, A. 2001. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in nod mice. J Autoimmun 16 (4):449-55
257. Sullivan, P. F., de Geus, E. J., Willemsen, G., et al. 2009. Genome-wide association for major depressive disorder: A possible role for the presynaptic protein piccolo. Mol Psychiatry 14 (4):359-75
258. Suzuki, E., Yagi, G., Nakaki, T., Kanba, S., and Asai, M. 2001. Elevated plasma nitrate levels in depressive states. J Affect Disord 63 (1-3):221-4
259. Suzuki, E., Yoshida, Y., Shibuya, A., and Miyaoka, H. 2003. Nitric oxide involvement in depression during interferon-alpha therapy. Int J Neuropsychopharmacol 6 (4):415-9
260. Szewczyk, B., Poleszak, E., Sowa-Kucna, M., et al. 2008. Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 60 (5):588-99
261. Takano, H., Manchikalapudi, S., Tang, X. L., et al. 1998. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98 (5):441-9
262. Taksande, B. G., Kotagale, N. R., Tripathi, S. J., Ugale, R. R., and Chopde, C. T. 2009. Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology 57 (4):415-24
263. Tanda, K., Nishi, A., Matsuo, N., et al. 2009. Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased d1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice. Mol Brain 2 (1):19
264. Thomsen, L. L. 1997. Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache. Cephalgia 17 (8):873-95
265. Thomsen, L. L., and Olesen, J. 1998. Nitric oxide theory of migraine. Clin Neurosci 5 (1):28-33
266. Tokarski, K., Bobula, B., Wabno, J., and Hess, G. 2008. Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex. Neuroscience 153 (3):789-95
267. Tsuchiya, T., Kishimoto, J., and Nakayama, Y. 1996. Marked increases in neuronal nitric oxide synthase (nNOS) mRNA and NADPH-diaphorase histostaining in adrenal cortex after immobilization stress in rats. Psychoneuroendocrinology 21 (3):287-93
268. Vallebuona, F., and Raiteri, M. 1994. Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity. J Neurosci 14 (1):134-9
269. Valtschanoff, J. G., Weinberg, R. J., Kharazia, V. N., Schmidt, H. H., Nakane, M., and Rustioni, A. 1993. Neurons in rat cerebral cortex that synthesize nitric oxide: NADPH diaphorase histochemistry, NOS immunocytochemistry, and colocalization with GABA. Neurosci Lett 157 (2):157-61
270. Volke, V., Wegener, G., Vasar, E., and Rosenberg, R. 1999. Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo. Brain Res 826 (2):303-5
271. Volke, V., Wegener, G., Bourin, M., and Vasar, E. 2003a. Antidepressant-and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res 140 (1-2):141-7
272. Volke, V., Wegener, G., and Vasar, E. 2003b. Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice. J Physiol Pharmacol 54 (4):653-60
273. Wallerath, T., Gath, I., Aulitzky, W. E., Pollock, J. S., Kleinert, H., and Förstermann, U. 1997. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost 77 (1):163-7
274. Wang, D., Yang, X. P., Liu, Y. H., Carretero, O. A., and LaPointe, M. C. 1999. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. Am J Hypertens 12 (2 Pt 1):174-82
275. Wang, D., An, S. C., and Zhang, X. 2008. Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neurosci Lett 433 (1):59-64
276. Wegener, G., Volke, V., and Rosenberg, R. 2000. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol 130 (3):575-80
277. Wegener, G., Volke, V., Bandpey, Z., and Rosenberg, R. 2001. Nitric oxide modulates lithium-induced conditioned taste aversion. Behav Brain Res 118 (2):195-200
278. Wegener, G., Volke, V., Harvey, B. H., and Rosenberg, R. 2003. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res 959 (1):128-34
279. Wegener, G., Harvey, B. H., Bonefeld, B., et al. 2010. Increased stress-evoked nitric oxide signalling in the flinders sensitive line (FSL) rat: A genetic animal model of depression. Int J Neuropsychopharmacol 13 (4):461-73
280. Weitzdoerfer, R., Hoeger, H., Engidawork, E., et al. 2004. Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance. Nitric Oxide 10 (3):130-40
281. Wiesinger, H. 2001. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 64 (4):365-91
282. Wiklund, N. P., Cellek, S., Leone, A. M., et al. 1997. Visualisation of nitric oxide released by nerve stimulation. J Neurosci Res 47 (2):224-32
283. Wiley, J. L., and Willmore, C. B. 2000. Effects of nitric oxide synthase inhibitors on timing and short-term memory in rats. Behav Pharmacol 11 (5):421-9
284. Xing, G., Chavko, M., Zhang, L. X., Yang, S., and Post, R. M. 2002. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr Res 58 (1):21-30
285. Yang, B., Larson, D. F., and Watson, R. R. 2004. Modulation of iNOS activity in age-related cardiac dysfunction. Life Sci 75 (6):655-67
286. Yang, X. C., and Reis, D. J. 1999. Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 288 (2):544-9
287. Yildiz, F., Erden, B. F., Ulak G., Utkan, T., and Gacar, N. 2000. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology (Berl) 149 (1):41-4
288. Yildiz Akar, F., Ulak, G., Tanyeri, P., Erden, F., Utkan, T., and Gacar, N. 2007. 7-Nitroindazole, a neuronal nitric oxide synthase inhibitor, impairs passive-avoidance and elevated plus-maze memory performance in rats. Pharmacol Biochem Behav 87 (4):434-43
289. Yildiz Akar, F., Celikyurt, I. K., Ulak, G., and Mutlu, O. 2009. Effects of l-arginine on 7-nitroindazole-induced reference and working memory performance of rats. Pharmacology 84 (4):211-18
290. Yu, Y. W., Chen, T. J., Wang, Y. C., Liou, Y. J., Hong, C. J., and Tsai, S. J. 2003. Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology 47 (3):137-40
291. Yun, H. Y., Gonzalez-Zulueta, M., Dawson, V. L., and Dawson, T. M. 1998. Nitric oxide mediates N-methyl-d-aspartate receptor-induced activation of p21ras. Proc Natl Acad Sci U S A 95 (10):5773-8
292. Zarate, C. A. Jr., Singh, J. B., Carlson, P. J., et al. 2006. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63 (8):856-64
293. Zhang, J., Huang, X. Y., Ye, M. L., et al. 2010. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors. J Neurosci 30 (7):2433-41
294. Zhang, R., Zhang, L., Zhang, Z., et al. 2001. A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann Neurol 50 (5):602-11
295. Zhou, Q. G., Hu, Y., Hua, Y., et al. 2007. Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. J Neurochem 103 (5):1843-54
296. Zhu, X. J., Hua, Y., Jiang, J., et al. 2006. Neuronal nitric oxide synthase-derived nitric oxide inhibits neurogenesis in the adult dentate gyrus by down-regulating cyclic amp response element binding protein phosphorylation. Neuroscience 141 (2):827-36
297. Zomkowski, A. D., Hammes, L., Lin, J., Calixto, J. B., Santos, A. R., and Rodrigues, A. L. 2002. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 13 (4):387-91
298. Zou, L. B., Yamada, K., Tanaka, T., Kameyama, T., and Nabeshima, T. 1998. Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats. Neuropharmacology 37 (3):323-30